双能CT在痛风分类标准中的表现:未分类关节炎的前瞻性研究
本研究纳入89例急性未分类单或少关节炎患者,以偏振显微镜滑液MSU晶体检测为参考,评估2015年ACR/EULAR痛风分类标准不同子集的性能及双能CT(DECT)的附加价值。结果显示,临床+血尿酸子集联合DECT并未提高AUC(均为0.81),但在显微镜阴性患者中DECT有附加分类价值,14/89例(16%)仅通过DECT才满足分类标准。
要点
- 临床+血尿酸子集较仅临床子集性能更优(AUC 0.81 vs 0.68-0.69)。
- 在临床+血尿酸子集基础上加DECT未改善分类性能(AUC均为0.81)。
- 滑液显微镜阴性时DECT有附加价值,14/89例(16%)仅靠DECT满足标准。
核心结论
- 在临床子集中加入血尿酸结果可改善痛风分类性能,但加入DECT结果未进一步改善。
- 在临床+血尿酸子集中加入DECT结果亦未改善分类性能。
- DECT在痛风分类中似有附加价值,尤其当滑液显微镜检查阴性时,14/89例(16%)患者仅使用DECT才满足分类标准。
研究设计与样本
- 前瞻性研究纳入89例急性、未分类单或少关节炎患者,均接受滑液分析及DECT检查。
- 以偏振显微镜下滑液MSU晶体检测结果为参考标准。
- 通过计算受试者工作特征曲线下面积(AUC)评估仅临床子集、临床+血尿酸子集及包含DECT的全集性能。
主要发现
- 89例中40例满足临床+血尿酸子集标准,49例(55%)不满足。
- 49例不满足者中30例显微镜结果阴性,其中15例DECT阳性;这15例中14例仅在加入DECT阳性结果后才满足全集标准。
- 仅临床子集不加和加DECT结果的AUC分别为0.68和0.69。
- 临床+血尿酸子集不加和加DECT的AUC均为0.81(结果无统计学显著性)。
关键数值与推荐
- 仅临床子集AUC:不加DECT为0.68,加DECT为0.69。
- 临床+血尿酸子集AUC:不加DECT和加DECT均为0.81(结果无统计学显著性)。
- 14/89例患者(16%)仅在使用DECT后才满足痛风分类标准。
临床怎么用
- 在未分类关节炎患者中,可优先采用临床+血尿酸子集进行痛风分类评估。
- 当滑液显微镜检查阴性时,DECT可能有助于识别仅通过DECT满足分类标准的痛风患者。
- 在已有临床+血尿酸子集结果时,加做DECT对分类性能的改善不明显。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To establish the performance of (subsets of) the 2015 ACR/EULAR gout classification criteria in patients with unclassified arthritis, and to determine the value of dual-energy CT (DECT) herein. Reference was the MSU crystal detection result in SF at polarization microscopy. METHODS: We included subjects with acute, unclassified mono or oligoarthritis, who underwent SF analysis and DECT. Performance was assessed by calculating area under the receiver operating characteristic curve of (i) the clinical criteria subset, (ii) the clinical+serum urate subset and (iii) the full set (including DECT). RESULTS: Of the 89 subjects enrolled, 40 met the clinical+serum urate subset criteria, and 49 (55%) subjects did not. Of these 49, 30 had a negative microscopy result, of whom 15 had positive DECT; of these 15, 14 met the full set criteria only after adding the positive DECT result. For the clinical-only subset, the areas under the curves (AUCs) were 0.68 and 0.69 without and with DECT result, respectively, and for the clinical+serum urate subset without and with DECT, AUCs were 0.81 and 0.81, respectively (results not significant). CONCLUSION: Adding the serum urate results to the clinical subset improves the performance, but adding the DECT result does not, neither does adding the DECT results to the clinical+serum urate subset. However, DECT seems to have an additive value in gout classification, especially when microscopy of SF is negative; 14/89 of patients (16%) only met the classification criteria with the use of DECT. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, NCT03038386.
引用
- Gamala M, Jacobs JWG, Linn-Rasker SF, et al. The performance of dual-energy CT in the classification criteria of gout: a prospective study in subjects with unclassified arthritis. Rheumatology (Oxford). 2020. PMID: 31504985. doi:10.1093/rheumatology/kez391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。